Ziyi Cao

Association of inflammatory biomarkers and pericoronary fat attenuation index with coronary functional ischemia in patients with metabolic dysfunction-associated fatty liver disease

Patients with metabolic dysfunction-associated fatty liver disease (MAFLD) and coronary heart disease (CHD) exhibit systemic and coronary inflammation. However, the value of integrating systemic inflammatory biomarkers and the pericoronary fat attenuation index (FAI) for identify...